Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2001-2-2
pubmed:abstractText
11beta-hydroxysteroid dehydrogenase type 1 (11betaHSD1) is an enzyme that converts cortisone to the active glucocorticoid, cortisol. Cortisol-cortisone interconversion plays a key role in the regulation of glucose metabolism, since mice deficient in 11betaHSD1 are resistant to diet-induced hyperglycemia. Peroxisome proliferator activator receptors (PPAR) are key regulators of glucose and lipid homeostasis. We observed a striking downregulation of murine hepatic 11betaHSD1 expression and activity after chronic treatment of wild-type mice with PPARalpha agonists, while 11betaHSD1 in the livers of PPARalpha knockout mice, or in mice treated for only 7 h with PPARalpha agonists, was unaltered. Our results are the first to show PPARalpha agonists can affect glucocorticoid metabolism in the liver by altering 11betaHSD1 expression after chronic treatment. Regulation of active glucocorticoid levels in the liver by PPARalpha agonists may in turn affect glucose metabolism, consistent with reports of their antidiabetic effects.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0006-291X
pubmed:author
pubmed:copyrightInfo
Copyright 2000 Academic Press.
pubmed:issnType
Print
pubmed:day
20
pubmed:volume
279
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
330-6
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:11118287-11-beta-Hydroxysteroid Dehydrogenases, pubmed-meshheading:11118287-Animals, pubmed-meshheading:11118287-Cells, Cultured, pubmed-meshheading:11118287-Cricetinae, pubmed-meshheading:11118287-DNA-Binding Proteins, pubmed-meshheading:11118287-Feedback, pubmed-meshheading:11118287-Fenofibrate, pubmed-meshheading:11118287-Gene Expression Regulation, Enzymologic, pubmed-meshheading:11118287-Hepatocytes, pubmed-meshheading:11118287-Hydroxysteroid Dehydrogenases, pubmed-meshheading:11118287-Liver, pubmed-meshheading:11118287-Mice, pubmed-meshheading:11118287-Mice, Knockout, pubmed-meshheading:11118287-Models, Biological, pubmed-meshheading:11118287-Peroxisome Proliferators, pubmed-meshheading:11118287-Pyrimidines, pubmed-meshheading:11118287-RNA, Messenger, pubmed-meshheading:11118287-Receptors, Cytoplasmic and Nuclear, pubmed-meshheading:11118287-Transcription, Genetic, pubmed-meshheading:11118287-Transcription Factors
pubmed:year
2000
pubmed:articleTitle
PPARalpha agonists reduce 11beta-hydroxysteroid dehydrogenase type 1 in the liver.
pubmed:affiliation
Department of Atherosclerosis and Endocrinology, Department of Molecular Endocrinology, Department of Genomic Pharmacology, Merck Research Laboratories, 126 East Lincoln Avenue, Rahway, New Jersey, USA. anne_vosatka@merck.com
pubmed:publicationType
Journal Article